Clinical Application of AMH Measurement in Assisted Reproduction

Clinical Application of AMH Measurement in Assisted Reproduction

Anti-Müllerian hormone reflects the continuum of the functional ovarian reserve, and as such can predict ovarian response to gonadotropin stimulation and be used to individualize treatment pathways to improve efficacy and safety. However, consistent with other biomarkers and age-based prediction mod...

Full description

Bibliographic Details
Main Authors:	Hang Wun Raymond Li, Scott M. Nelson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Endocrinology
Subjects:	anti-Müllerian hormone assisted reproduction in vitro fertilization intrauterine insemination ovarian response gonadotropin dosing
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2020.606744/full

Similar Items

Demographic characteristics and AMH levels in rural and urban women participating in an IVF programme
by: Michał Kunicki, et al.
Published: (2018-03-01)

Live Birth Rate following Intrauterine Insemination in Women with Low or Very Low Level of Serum Anti-müllerian Hormone
by: Marzieh Mehrafza, et al.
Published: (2020-07-01)

Effects of total gonadotropin dose on embryo quality and clinical outcomes with AMH stratification in IVF cycles: a retrospective analysis of 12,588 patients
by: Xiaoxue Shen, et al.
Published: (2024-03-01)

Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes
by: Rena Ishii, et al.
Published: (2019-07-01)

AMH and AMHR2 Polymorphisms and AMH Serum Level Can Predict Assisted Reproduction Outcomes: A Cross-Sectional Study
by: Carla Peluso, et al.
Published: (2015-03-01)

The role of anti-mullerian hormone in assisted reproduction
by: Ahmed Nasr
Published: (2012-09-01)

The role of Anti-Mullerian hormone in assisted reproduction
by: Aboubakr Mohamed Elnashar
Published: (2012-09-01)

Editorial: Clinical Applications of Anti-Mullerian Hormone and Its Measurement in Reproductive Medicine and Women’s Health
by: Hang Wun Raymond Li, et al.
Published: (2022-03-01)

Functional Activity of Recombinant Forms of Amh and Synergistic Action with Fsh in European Sea Bass Ovary
by: Cinta Zapater, et al.
Published: (2021-09-01)

The use of gonadotropin-releasing hormone antagonist in women undergoing intrauterine insemination
by: M Yousef Elsemary, et al.
Published: (2019-01-01)

Factors influencing the pregnancy outcome of intrauterine insemination and follow-up treatment
by: Xuan Huang, et al.
Published: (2023-01-01)

Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women?
by: Hui Huang, et al.
Published: (2023-12-01)

Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH)
by: Han-Chih Hsieh, et al.
Published: (2020-04-01)

Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
by: Liang-Hsuan Chen, et al.
Published: (2021-07-01)

Establishment of a Reference Range for AMH and Correlation between AMH and Cardiovascular Risk Factors in Healthy Women of Reproductive Age in Urumqi
by: Zynat JAZYRA·, Kaidi ZHANG, Fuhui MA, Danyang DU, Lingling DONG, Yan HENG, Xiaoyuan MA, Yanying GUO
Published: (2022-08-01)

The AMH genotype (rs10407022 T>G) is associated with circulating AMH levels in boys, but not in girls
by: Iben Katinka Greiber, et al.
Published: (2018-02-01)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
by: Cota Ana Marcia M, et al.
Published: (2012-04-01)

Evaluation and Interpretation of AMH in Female Infertility
by: Şule Atalay Mert, et al.
Published: (2022-10-01)

Anti-Mullerian Hormone (AMH) as a Predictor of Ovarian Response to Clomiphene Citrate in Polycystic Ovarian Syndrome
by: Serajoom Munira, et al.
Published: (2021-09-01)

The impact of high circulating anti-müllerian hormone on endometrial thickness and outcome of assisted reproductive technology in women with polycystic ovarian syndrome: A cohort study
by: Ahmed Aboelfadle Mohamed, et al.
Published: (2022-01-01)

Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis
by: Tianyi Yuwen, et al.
Published: (2023-10-01)

Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study
by: Sarah McCredie, et al.
Published: (2023-04-01)

Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study
by: A. G. Grynnerup, et al.
Published: (2019-01-01)

A multicenter phase IV study to investigate the immunogenicity of recombinant human follicle-stimulating hormone and its impact on clinical outcomes in females undergoing controlled ovarian stimulation
by: Abha Majumdar, et al.
Published: (2019-01-01)

AMH concentrations in infancy and mid-childhood predict ovarian activity in adolescence: A long-term longitudinal study of healthy girlsResearch in context
by: Casper P. Hagen, et al.
Published: (2023-01-01)

Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism
by: Monna Pandurangi, et al.
Published: (2015-01-01)

Retrospective analysis: The application of human menopausal gonadotropin combined with letrozole for IUI in patients undergoing artificial insemination by husband due to unexplained or mild male factors
by: Hua-qing Li, et al.
Published: (2022-12-01)

Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction
by: Y Himabindu, et al.
Published: (2013-01-01)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
by: Shikha Jain, et al.
Published: (2016-01-01)

To compare the effect of GnRH agonist versus human chorionic gonadotropin (HCG) trigger on clinical pregnancy rate in intrauterine insemination cycle
by: Rashmi Sharma, et al.
Published: (2021-01-01)

The relationship between anti-mullerian hormone and ovarian response and fertility outcome in infertile women undergoing assisted reproductive techniques (ART) and IUI
by: Fariba Seyedoshohadaei, et al.
Published: (2023-03-01)

Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction
by: Jason R Kovac, et al.
Published: (2017-01-01)

Assisted reproductive technology and interactions between serum basal FSH/LH and ovarian sensitivity index
by: Yumei He, et al.
Published: (2023-05-01)

A COMPARISON OF CLOMIPHENE CITRATE AND SEQUENTIAL CLOMIPHENE CITRATE PLUS HUMAN MENOPAUSAL GONADOTROPIN FOR USE IN CONJUNCTION WITH INTRAUTERINE INSEMINATION
by: B. H. Rashidi, et al.
Published: (2005-06-01)

A COMPARISON OF CLOMIPHENE CITRATE AND SEQUENTIAL CLOMIPHENE CITRATE PLUS HUMAN MENOPAUSAL GONADOTROPIN FOR USE IN CONJUNCTION WITH INTRAUTERINE INSEMINATION
by: B. H. Rashidi, et al.
Published: (2005-06-01)

Impact of intrauterine administration of human chorionic gonadotropin before intrauterine insemination in infertile women: A randomized controlled trial
by: Leena Wadhwa, et al.
Published: (2021-01-01)

Anti-Mullerian Hormone as A Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
by: Parvin Fallahi, et al.
Published: (2011-11-01)

Anti-Mullerian Hormone as a Predictive Factor in Assisted Reproductive Technique of Polycystic Ovary Syndrome Patients
by: Ashraf Aleyasin, et al.
Published: (2011-11-01)

Which Ovarian Reserve Marker is More Reliable in IVF Patients with AMH and AFC Discordance?
by: Eun Hee Yu, et al.
Published: (2024-02-01)

Assisted Reproductive Technology Results Using Donor or Partner Sperm: A Danish Nationwide Register-Based Cohort Study
by: Laura Catalini, et al.
Published: (2023-03-01)